Cardiology
Dermatology
Endocrinology
Gastroenterology
Immunology
Ophthalmology
Primare Care / Internal Medicine
Psychiatry
Pulmonology
The OptimizeRx Platform
Life science brands make significant investments in medication affordability programs for patients.
OptimizeRx Financial Messaging helps pharma marketers turn those investments into demonstrated increases in script volumes by:
- Placing your savings offer directly in the EHR workflow of HCPs at the moment your brand is being considered or prescribed
- Equipping HCPs to discuss medication cost and assistance programs with patients
- Automatically routing savings, copay or voucher offer to the patient’s preferred pharmacy
- Providing mobile copay activation from the point-of-care and brand website
The result? HCPs are more confident writing brand prescriptions, and patients are able to afford their medication more easily – generating increased script volumes.
Why Do Pharma Marketers Choose OptimizeRx Financial Messaging?
HCP Reach
Our programs reach unique HCPs that are not available in other networks.
Provider Engagement
We average a 65% provider list match, and an 86% provider engagement rate.
Measurable ROI
We consistently deliver double- or triple-digital ROI to our clients.
Mobile Access
We provide mobile copay access and point-of-care activation for easier sign-up and use.
35K Incremental Prescriptions
200+ New Brand Prescribers
A competitive therapy area, cheaper alternatives, and a less-desirable route of administration didn’t stop OptimizeRx from delivering massive results for a cardiovascular brand.
58% Prescription Increase
51% Prescribing Rate
This respiratory brand needed to transition patients to a newer version of therapy, but cost was a disincentive to switching. Our program saw targeted physicians increase prescribing activity – and generated triple-digit ROI.
13K Incremental Prescriptions
300+ New Brand Prescribers
COVID-19 stalled provider calls and sample requests for this add-on depression therapy, but our program helped build brand recognition and prescription volumes – especially among new providers.
6.8K Incremental Prescriptions
54% Average Script Lift
The competitive nature of the diabetes market meant that this brand’s sales had started to plateau, but raising awareness of financial support options helped patients start and stay on therapy.
3.7K+ New-to-Brand Prescriptions
83% Prescribing Rate
When a mature cardiovascular brand was seeking to maintain market share after LOE, we helped them keep cost on par while still demonstrating growth. Did we mention the ROI was nearly unbelievable?
58% Sales Lift
$389K Incremental Sales
Multiple approved and launching competitors meant that this osteoarthritis therapy needed to boost brand recognition with patients and providers. Financial messaging provided the “in” the brand needed.
Ready to start driving more prescriptions by increasing patient affordability? Request a quote for your brand today.
